- Amended Statement of Beneficial Ownership (3/A)
06 Octubre 2011 - 1:11PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Expires:
November 30, 2011
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Lee Tong Tai
|
2. Date of Event Requiring Statement (MM/DD/YYYY)
9/21/2011
|
3. Issuer Name
and
Ticker or Trading Symbol
Hubei Minkang Pharmaceutical Ltd. [HBMK]
|
(Last)
(First)
(Middle)
2 NORMANTON PARK, #04-151, NORMANTON PARK
|
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
__
X
__ Director
___
X
___ 10% Owner
___
X
___ Officer (give title below)
_____ Other (specify below)
President and CEO /
|
(Street)
SINGAPORE, U0 000000
(City)
(State)
(Zip)
|
5. If Amendment, Date Original Filed
(MM/DD/YYYY)
9/29/2011
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security
(Instr. 4)
|
2. Amount of Securities Beneficially Owned
(Instr. 4)
|
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
|
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Common Shares
|
1984170
(1)
|
I
|
By wife
|
Common Shares
|
962993
(1)
(2)
|
I
|
By son
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 4)
|
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
|
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
|
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Explanation of Responses:
|
(
1)
|
These shares were previously reported as being directly owned in the reporting person's original Form 3, and are indirectly owned by the reporting person as indicated.
|
(
2)
|
The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Lee Tong Tai
2 NORMANTON PARK, #04-151
NORMANTON PARK
SINGAPORE, U0 000000
|
X
|
X
|
President and CEO
|
|
Signatures
|
/s/ Lee Tong Tai
|
|
10/6/2011
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 5(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Hubei Minkang Pharmaceut... (GM) (USOTC:HBMK)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Hubei Minkang Pharmaceut... (GM) (USOTC:HBMK)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Hubei Minkang Pharmaceutical Ltd (GM) (OTCMarkets): 0 recent articles
Más de Artículos de Noticias